Skip to content
Biopharmaceutical Contract Manufacturing Market
Biopharmaceutical Contract Manufacturing Market

Press release -

At 8.17% CAGR, Biopharmaceutical Contract Manufacturing Market size is expected to reach USD 21.01 Billion by 2025

Biopharmaceutical Contract Manufacturing Market Size By Therapeutic Area (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others), By Product (Biologics, Biosimilars), By Application (Clinical, Commercial, Active Pharmaceutical Ingredient (API), Finish Product ) Forecast To 2027

Increasing development of biologic drugs to achieve goals toward commercialization, rapid expansion of the biologics’ markets and continuous rising outsourcing activities by biopharmaceutical companies of non-core businesses are major factors driving the growth of the Global Biopharmaceutical Contract Manufacturing Market.

"Global Biopharmaceutical Contract Manufacturing Market is valued at USD 12.13 Billion in 2018 and expected to reach USD 21.01 Billion by 2025 with the CAGR of 8.17% over the forecast period."

Global Biopharmaceutical Contract Manufacturing Market is segmented on the basis of therapeutic area, product, application and by region & country level. By therapeutic area, the market is classified into autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders and others. Based on product, the market is classified into biologics (monoclonal antibodies, recombinant hormones, vaccines and others) and biosimilars. On the basis of application, the market is classified into clinical, commercial, active pharmaceutical ingredient (API) and finish product.

The regions covered in this biopharmaceutical contract manufacturing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of biopharmaceutical contract manufacturing market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Get Sample of the report:

Biopharmaceutical Contract Manufacturing Companies

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Boehringer Ingelheim International GmbH
  • Inno Biologics Ventures Sdn Bhd
  • AbbVie Inc
  • Wuxi Biologics
  • General Electric

Contract manufacturing includes the production of goods by firms, under their own brand name or label of another firm. Contract manufacturers offer services to numerous bio firms based on their own or consumers' designs and specifications. From big bio pharmaceutical to smaller pharma, contract manufacturing helps to build strategy for various industry players. Biopharmaceutical companies are increasingly depending on contract manufacturing to meet basic needs and specialized competencies. The companies are focusing on saving costs and product development time while improving efficiency and productivity. Using contract manufacturing helps bio-pharmaceutical companies to achieve their corporate goals by saving valuable resources that would require for capital investment in facilities and equipment. Furthermore, contract manufacturing has several advantages such as rapid development of innovative drugs and faster launch of clinical and commercial products.

Market Segmentation-

By Therapeutic Area: Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Others

By Product: Biologics (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Others), Biosimilars

By Application: Clinical, Commercial, Active Pharmaceutical Ingredient (API), Finish Product

By Regional

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Global Biopharmaceutical Contract Manufacturing Market Dynamics-

Increasing development of biologic drugs to achieve goals toward commercialization, rapid expansion of the biologics markets and continuous rise in outsourcing activities by biopharmaceutical companies of non-core businesses are some of the major factors contributing to an increased demand of the biopharmaceutical contract manufacturing. For example; Small to medium sized pharmaceutical and biotech companies are aiming to bring 50% of new drug molecules to market in the coming years. It is estimated that, the total outsourced manufacturing market reached around USD 70.16 billion in 2015 growing at a 6.2%. Currently, biotechnology companies are constantly outsourcing contract manufacturing organizations (CMOs) in order to meet their fill-and-finish operations and reduce risk. In addition, other key factors driving the market growth include significant efforts have taken by biopharmaceutical industry players to cut costs as well as increasing biotech firms that do not have in-house manufacturing capabilities. However, lack of skilled professionals and intense competition may obstruct the growth of this market.

North America is expected to dominate the Global Biopharmaceutical Contract Manufacturing Market

North America holds the major market share of the biopharmaceutical contract manufacturing due to the existence of leading biopharmaceutical industry players along with the advanced manufacturing capabilities, high R&D investments and favorable government policies in this region. For example; the overall economic impact of the biopharmaceutical industry on the U.S. economy keeps growing at a significant pace. The biopharmaceutical industry accounted for around USD 1.2 trillion in economic output, represented 3.8 % of total U.S. output in 2014.

Asia pacific is estimated to be the fastest growing region for market expansion. This growth is mainly attributed to rapidly increasing biopharmaceutical manufacturing and adoption of new technologies for vaccine production in this region.

Read More:

Related links



We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. Phone : +917447409162 Email :  

Press contacts

Editorial Team

Editorial Team

Press contact Content Editors +44-2038074155
Aniket patil

Aniket patil

Press contact Co-Founder, Marketing Director +917447409161
Vishal Sawant

Vishal Sawant

Press contact Business Development Director +917447409162

We Accelerate your Growth !!!

Behind every successful strategy lies decision grade research. At BrandEssence, we help businesses hone their strategies with the power of actionable insights that we uncover through methodical research. Various influences determine the success of a product and service launch – and it takes a scientific study of focus groups to unravel opinions, perceptions, and expectations of stakeholders regarding an existing or proposed launch of service/product.
Brandessence has mastered the science of market research, straddling industries and domains with an expertise that stems from the brilliance of analysts powered by cutting-edge research tools. The best methodologies include quantitative and qualitative research in addition to multi-variable testing for homing in on the best approach.
Every single report that we at BrandEssence compile is a narrative by itself. Devoid of clutter, filled with actionable insights, backed by statistical data, with inferences drawn by experts, the crisp reports present the hard facts, helping businesses chalk out strategies. Perspectives at different hierarchies are not the same, and it takes an expert service like ours to put reports in the right perspective. A C-Suite Executive sees things differently while a business development manager has a different view of the same aspect. Reports need to consider the different perspectives and table the findings in a manner that will help all stakeholders to see the larger picture, with great granular detail. And this is the presentation aspect that our analysts have conquered.
We work for following Industries :
● Automotive
● Packaging
● Healthcare
● Chemicals
● Defense
● Medical Devices
● Aviation
● Construction
● Healthcare IT
● Renewable Energy
● Energy: Oil & Gas
● Metals and Minerals
● Agriculture Industry
● Biotechnology
● Heavy Industrial Sector
● Electronics
● Semiconductors
● Telecommunication
● Pharmaceuticals
● Technology and Media

Brandessence Market Research and Consulting Pvt ltd.
Office No 101, City Point, Survey No. 171/9, Bhekrai Nagar, Near HP Petrol Pump, Hadapsar–Saswad Road
412308 Pune
Visit our other newsrooms